chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This pt needed IZ for college entrance. On 4/12/00, pt given updated IZ and to follow-up in 1 month, for Hep-B. On 4/24/00, pt had gotten erythema in the area, but then developed 2 lumps which now are draining. Dx: obvious abscess formation. She had open/drainage at injection site. She was treated with Keflex, heat to area and recheck if further problems. This is probably the result of her IZ to either DT or Hep-B, which were the 2 that were marked on that arm.
Severe chills w/ teeth chattering, sweats.  Hair loss reported to start 10/15/2013, dermatologist told patient that may be due to preservative in vaccine.
Giving the monovalent vaccine as booster; No adverse event; This spontaneous case was reported by a patient and describes the occurrence of WRONG PRODUCT ADMINISTERED (Giving the monovalent vaccine as booster) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (Giving the monovalent vaccine as booster) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (Giving the monovalent vaccine as booster) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            The concomitant medication was not reported by reporter. Caller stated that the pharmacy staff where patient received the booster told that they were still giving the monovalent vaccine as booster. The treatment medication was not reported by reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-079228, US-MODERNATX, INC.-MOD-2021-079240 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-079228:(same reporter) US-MODERNATX, INC.-MOD-2021-079240:(same reporter)
Joint and Muscle Pain of whole body, beginning with the right arm the day after the injection spreading to the whole body during the following days.  Dizziness and inability to concentrate.  Extreme fatigue.  Painful cramping in muscles.
This case was reported by a consumer via call center representative and described the occurrence of injection site itching in a adult female patient who received dTpa vaccine. On 16th July 2017, the patient received dTpa vaccine. On 17th July 2017, 1 days after receiving dTpa vaccine, the patient experienced injection site itching, injection site erythema, injection site pain and injection site swelling. On an unknown date, the outcome of the injection site itching and injection site swelling were unknown and the outcome of the injection site erythema and injection site pain were unchanged. It was unknown if the reporter considered the injection site itching, injection site erythema, injection site pain and injection site swelling to be related to dTpa vaccine. Additional details were provided as follows: The patient came in on the pregnancy registry line, but she was not pregnant. The patient was nearly 70 at the time of reporting. The age at vaccination was not provided. The patient was vaccinated with an unknown Tdap vaccine. The patient began to experience injection site reactions consisting of itching, pain, redness, and swelling. When the patient went to the pharmacy to inform them, they referred her to GlaxoSmithKline. No idea what the brand was. The patient had denied permission to contact their physician.
Patient reports increasing SOB but states that he has been SOB for  years. Unknown if increasing SOB is related to vaccine. He stated he uses two  inhalers and will notify his PCP with any additional concerns. Patient verbalized  understanding to go to nearest emergency department or call 9-1-1 if his SOB  increases more or he thinks he needs medical attention. Patient reports no other  signs and symptoms currently. Patient instructed to monitor for the following  symptoms over the course of three weeks after the vaccination. * A headache that  occurs 6 days or more after vaccination * A headache that is different from other  headaches you have had * Confusion or trouble thinking clearly * Visual changes,  such as blurry vision * Weakness, numbness, or trouble moving one or more parts  of your body of your body, trouble speaking or seizures * Tiny spots under the skin  away from the area where you had the infection (this is a sign of low platelets)  Patient instructed to contact their health care provider if one or more of these  symptoms develop. If symptoms are severe, seek immediate medical attention at  the closest emergency department or call 9-1-1
neuropathy; chronic inflammatory demyelinating polyneuropathy (CIDP); This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. Information on the patient's concurrent conditions, medical history or concomitant therapy was not reported.  On an unknown date, the patient was inoculated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, route of administration and anatomical location were not reported) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). On an unknown date, after receiving zoster vaccine live (ZOSTAVAX), patient suffered neuropathy and chronic inflammatory demyelinating polyneuropathy (CIDP). As a result of these symptoms, patient was seen and treated by medical providers and was still under their care.  As a direct and proximate result of zoster vaccine live (ZOSTAVAX), patient's symptoms have resulted in physical limitations not present prior to using the vaccine. Patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of patient's condition. As a result of zoster vaccine live (ZOSTAVAX), patient sustained severe and permanent personal injuries. Further, as a tragic consequence of Company's wrongful conduct, patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of Company's conduct, patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages.  Upon internal review, the events of neuropathy and CIDP were considered to be medically significant.
Breakthrough case admission after three vaccines  Pfizer 4/19/21 Lot# EN6202;  Pfizer 5/10/21 Lot# ER2613;  PFIZER 11/15/21 lOT#FF2593
the needle leaked because the patient pulled their arm away; A spontaneous report was received from  a pharmacist concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and had the needle leaked because the patient pulled their arm away.   No medical history was reported. No relevant concomitant medications were reported.  On an unknown date, the patient received their a dose of mRNA-1273 (Batch number: not provided), intramuscularly for the prophylaxis of COVID-19 infection.   On an unknown date, the reporter stated that the needle leaked because the patient pulled their arm away. No further information was provided.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.  On an unknown date, the needle leaked because the patient pulled their arm away was considered resolved.; Reporter's Comments: This report refers to a case of accidental underdose for mRNA-1273 (lot # 024M20A) with no associated AEs reported.
One episode of jerking movements of arms and legs lasting 10 seconds with rolling back of eyeballs on 9/25/05 at 11PM, no treatment.
Pt recvd 1st dose of vax on 16AUG91 & w/in 1 wk of vax pt exp dizziness, double vision & ringing in ears;
feeling crappy; low grade fever; body ache; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (feeling crappy), PYREXIA (low grade fever), MYALGIA (body ache) and HEADACHE (headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Feeling unwell on 03-Feb-2021. Concomitant products included PARACETAMOL (TYLENOL) from 03-Feb-2021 to an unknown date for Feeling unwell.    On 03-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced VACCINATION COMPLICATION (feeling crappy), PYREXIA (low grade fever), MYALGIA (body ache) and HEADACHE (headache). At the time of the report, VACCINATION COMPLICATION (feeling crappy), PYREXIA (low grade fever), MYALGIA (body ache) and HEADACHE (headache) outcome was unknown. Not Provided          The patient did not take anything to treat her symptoms.
feeling achy; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (feeling achy) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Jun-2021, the patient experienced MYALGIA (feeling achy). At the time of the report, MYALGIA (feeling achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.   No treatment was reported for the events.
I had diarrhea, bad headaches, side stomach pains, I couldn't get an erection, shooting pains in my legs, fatigue, loss of appetite, felt weak, heavier thoughts, talking to myself more, my eye was getting lazier. I am still waiting to go to the hospital.
Local symptom: discomfort. General symptoms: Chills, fever, headaches, joint pains, muscle pains, fatigue, nausea, diarrhea, swollen neck-left neck and face, tooth pain, dizzy, concentration, memory problems, forgetting words. ,  Narrative:   Other Relevant History:
Difficulty breathing, eyes, throat, lips swelling, itchy throat, watery eyes, coughing.
Approximately 30 hours of fever  (2.4 to 3.4 degrees above normal), extreme fatigue, lack of appetite, increased thirst (dry mouth) & exacerbated tinnitus.  I had tinnitus before but it is much more pronounced now and has not resolved. Other symptoms resolved  on their own.
Pt was hospitalized at hospital for treatment of intussusception treated with an contrast enema. Received ROTATEQ 6/16/07, 8/23/07.  04/09/2008 MR received for DOS 1/13-14/2008 with D/C DX: Intussusception. Pt presented to ER with acute onset of bilious vomiting  and abdominal discomfort.  PE (+) for abdominal tenderness and RLQ emptiness. Air contrast barium enema able to reduce IS.  Normal BMs by HD#3.   PCP f/U 1/17/08 with report of normal stool.
On 11/18/2021. I woke up in the middle of the night with severe back pain and chills. Over the next couple of days, the pain would migrate to my chest and I would start coughing up blood. I went to the ER on 11/21/2021, and they ran a bunch of tests including cat scans, blood work and x rays. After about 6 hours, they came back and told me I had Acute pulmonary embolisms in both lungs. They prescribed me Eliquis 10mg BID x 10 days. My coughing up blood lasted for about 2 more weeks after this then subsided. I followed up with my cardiologist after the ER visit and, due to a previously diagnosed atrial fibrillation condition, they decided to continue me on the Eliquis 5mg for about 6 months. After seeing a hematologist, they felt sure that my situation was likely a reaction to the J&J vaccine as he had seen similar cases with the same timeline as mine. I still experience shortness of breath and fatigue to this day. I was scheduled for a cardioversion for the atrial fibrillation but tested positive for COVID on 01/14/2022.
Within 10 minutes I felt faint, my neck tightened, headache started..  Still have a headache 5 weeks later
Information has been received from a physician referring to an unspecified number of patients of unknown age and gender. The patients' concurrent conditions and medical history were not reported.  On unknown dates, the patients were vaccinated with improperly stored GARDASIL 9 (lot # L014415, expiration date 25-JUL-2017, strength, dose and route were unknown). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
About five hours after receiving the shot I got really congested and started feeling dizzy.  Still congested and feeling dizzy the following day
PATIENT MISTAKENLY RECEIVED 2 SHOTS OF RSV VACCINES INSTEAD OF 1 MODERNA AND 1 RSV
This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Bad back) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Bad back). At the time of the report, BACK PAIN (Bad back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. The patient took unspecified medications as treatment.
Numbness in hands and feet; Tingling in hands and feet; Pain in hands; Redness in hands; Swelling in hands; This is a spontaneous report from a contactable other healthcare professional, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an intramuscular route of administration in the left arm on 09Jan2021 at 12:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. No relevant medical history was reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included duloxetine hydrochloride (CYMBALTA) taken from an unknown date for an unknown indication and birth control pill (MANUFACTURER UNKNOWN) taken from an unknown date. The patient had no allergies to medications, food, or other products. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an intramuscular route of administration in the left arm on 19Dec2020 at 12:00 (at the age of 31-years-old) as a single dose for COVID-19 immunisation. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 25Mar2021 at 13:00 the patient experienced numbness and tingling in hands and feet 3 months later. The patient also experienced pain in hands, redness in hands and swelling in hands on 25Mar2021 at 13:00. The adverse events resulted in a visit to the doctor or other healthcare professional office/clinic visit. Therapeutic measures included intake of naproxen for the reported events. The clinical outcome of the events numbness and tingling in hands and feet, pain in hands, redness in hands and swelling in hands were not resolved at the time of this report.   No follow-up attempts are needed; information about lot number cannot be obtained.
Rash on arm at site of injection. Hot, red, hard and sore 7. Days after receiving vaccine
Local redness/pain at injection site (L) deltoid. Since time of vaccine - patient felt "odd" heart felt racing; nausea. (2d later) had fever 101 degrees felt shaky/chills. Pt office and take BENADRYL. Heart racing.
Patient received immunization on 10/17/2018. Patient reported to our customer complaint system 03/01/2019 that she had a sore arm that she sought medical treatment for soft tissue injury that resulted in a "frozen shoulder".
On the 18th of April 2004 I was immunizied for the 6th time for the Anthrax series. Within hrs I had began to experience joint pain in my shoulders and knees. My left Knee experienced the most inflamation and edema. Doctor examined me and said it was an acute reaction and should subside within 10 days. I asked at that time to have it recorded in my medical record.symptoms were within 3 hrs of the innoculation. It has been a month and the symptoms have not subsided.
Completed covid vaccine series 1/19/21, became symptomatic on 3/29/21 and tested positive for covid on 3/30/21.
I have arthritis in a joint in my left thumb.  The morning after the injection I could hardly move my thumb.  I took a Naproxen 500 mg tablet after breakfast and the pain started to lessen in about 30 minutes.  I had all the other symptoms described with the second dose but felt better by the second morning after the injection.  I still have slight soreness at the injection sight on the third day.
I experienced extreme exhaustion and lethargy that went on for at least 3 days. I thought that I may be depressed but I did not have any reason, so I called my doctor and she advised that if it was not better or I developed other symptoms within one week to come in. The symptoms are almost completely resolved. I am able to do my normal daily functions. I did experience extreme body aches and had to lay down. I took 2 Tylenol at that point and rested. I had been monitoring my temperature but never did have one.
Within 24 hrs uncontrollable cry overnight and was witness at the office. Tylenol 0.4 ml P.O given at the office.
Patient reports diarrhea & chills started day after admin., 2nd lasted almost 4 days.
On 5/4/00 at 18:00, pt began itching and broke out all over her body with hives. Hives remain. Pt stated she was dizzy for 2 days following the injection and had a headache. Pt was referred to physician.
Pt recvd flu vax & devel inflammation, induration, swelling, & warmth @ the site of inject;
only the liquid portion of Menveo; only the liquid portion of Menveo; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a female patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA944A, expiry date 31-JUL-2024) for prophylaxis.   On 06-JUL-2023, the patient received Menveo. On 06-JUL-2023, an unknown time after receiving Menveo, the patient experienced inappropriate preparation of medication (Verbatim: only the liquid portion of Menveo) and inappropriate dose of vaccine administered (Verbatim: only the liquid portion of Menveo). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 18-JUL-2023 The patient received only the liquid portion of Menveo, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter did not consent to follow up.
Redness and soreness after receiving vaccine which went away. Approximately 7 days after receiving vaccine, patient is complaining of a rash in the injection area as well as stiffness.
Unprovoked pulmonary embolisms (PEs). I am uncertain why this patient developed bilateral pulmonary embolisms. patient to hold on receiving her 2nd Moderna vaccine. obtain hematological consultation for input in regard to the patient receiving another Moderna vaccine, and also ask Hematology to proceed with any further evaluation and workup in regard to these unprovoked PEs, as they deem appropriate.  6 months of anticoagulation, but I would also like input from Hematology in regard to this.
102 F temperature this morning.  Taken with two different oral thermometers.    Temp has now subsided to 99.5 F. Chills. headache, nausea, painful site injection arm, lethargy.
PT was given DTaP and IPV in left leg on 4/25/06 on 4/27/06 mother called said child's leg was red. She was told that was normal but to Put cool clothes on it about QID. On 4/28/06 mother called our office said child now had watery type blisters we told her to come in. Dr took pictures
fever; muscle aches; headaches; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 26Sep2021 12:00 (Lot number: FF8835) at the age of 68 years as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "diabetes" (unspecified if ongoing). Concomitant medication(s) included: METFORMIN. The following information was reported: PYREXIA (non-serious) with onset 27Sep2021 12:00, outcome "unknown", described as "fever"; MYALGIA (non-serious) with onset 27Sep2021 12:00, outcome "unknown", described as "muscle aches"; HEADACHE (non-serious) with onset 27Sep2021 12:00, outcome "unknown", described as "headaches". Therapeutic measures were not taken as a result of pyrexia, myalgia, headache.  Additional information: The most recent COVID-19 vaccine was administered at Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received metformin within 2 weeks of vaccination. Adverse event did not require a visit to Emergency Room/Physician Office. The patient did not receive any treatment for the events. No prolonged hospitalization was reported. Prior to vaccination, the patient was not diagnosed with COVID-19; Since the vaccination, the patient has not been tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
This spontaneous report was received from a female consumer of unknown age reporting on herself via Pfizer (MFR # 2015293612) on 10-SEP-2015. The patient's concurrent conditions included a bladder infection and sore throat. On 27-AUG-2015, also reported as several days ago, on this past Thursday, the patient was vaccinated with a PNEUMOVAX 23 (manufacturer unknown) (dose, route, lot No. and expiration date were unknown). Other suspect therapies included fluticasone for sore throat and macrobid for bladder infection (dose and frequency were not informed). On 29-AUG-2015, the patient experienced fatigue, loss of appetite, muscle aches, a little breathless, felt feverish and felt quite sick. The patient had not been noticed her physician about these adverse events still. At the time of this report, the outcome of fatigue, loss of appetite, muscle aches, a little breathless, felt feverish and felt quite sick was recovering. The reporter considered as related the relationship between the events and PNEUMOVAX 23 (manufacturer unknown). No product quality issue was involved. Additional information is not expected because the reporter declined to provide additional information for this report.